-1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT2_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)))))))
+1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)))))))
+1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT2_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT2_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT1_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT2_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB also)) (VP (VBD interacted) (PP (IN with) (NP (NP (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (NN catenin) (NN gene) (NN family))) (PP (VBG including) (NP (NP (NN _PROT2_)) (CC and) (NP (NN gamma-catenin)))))))))
-1 #(S1 (S (NP (NP (DT The) (NN interaction)) (PP (IN with) (NP (NP (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (JJ direct)))))) (, ,) (SBAR (IN as) (S (NP (DT the) (NN interaction)) (VP (VBZ occurs) (PP (IN in) (NP (NP (NN K562) (NNS cells)) (VP (VBG lacking) (NP (NP (JJ functional) (JJ adherens) (NNS junctions)) (CC and) (NP (NN _PROT2_) (NN expression))))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_AND_PROT2_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT1_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_AND_PROT2_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
+1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT2_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT1_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT1_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
+1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP have) (VP (VBN cloned) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (DT the) (JJ human) (CC and) (NN mouse) (NNS homologs)) (PP (IN of) (NP (DT the) (NN yeast) (NN U3) (JJ snoRNP-associated) (NNS proteins) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT1_))) (, ,) (NP (NN mouse) (NN _PROT2_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT1_))) (, ,) (NP (NN mouse) (NN _PROT_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT_))) (, ,) (NP (NN mouse) (NN _PROT1_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (DT the) (JJ full-length) (NN _PROT1_))) (PP (IN without) (NP (NNS RSRS))) (PP (IN in) (NP (NN U1240MG) (NN glioblastoma) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN repression)) (PP (IN of) (NP (JJ _PROT2_) (NN promoter) (NN activity))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ relative) (NN abundance)) (PP (IN of) (NP (NP (DT the) (CD two) (NN splice) (NNS variants)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NN brain)))))) (VP (MD could) (VP (VB be) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN for) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN _PROT2_)))))))))))))
